
Boston Scientific's Agent Drug-Coated Balloon (DCB) receives FDA approval for treating coronary in-stent restenosis, showing superior outcomes compared to conventional treatments.


coremsg

The Agent DCB, from Boston Scientific, was superior to uncoated balloon angioplasty for the treatment of coronary artery in-stent restenosis in a pivotal trial.

FDA OKs First Drug-Coated Balloon for In-Stent Restenosis

fda-approves-boston-scientific-s-agent-drug-coated-balloon-for-in-stent-restenosis


FDA Approves Boston Scientific's Agent Drug-Coated Balloon for In-Stent Restenosis
